chr7-80656534-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001001548.3(CD36):​c.121-6T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.102 in 1,612,296 control chromosomes in the GnomAD database, including 13,527 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 2027 hom., cov: 32)
Exomes 𝑓: 0.099 ( 11500 hom. )

Consequence

CD36
NM_001001548.3 splice_region, intron

Scores

2
Splicing: ADA: 0.0002977
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.01

Publications

39 publications found
Variant links:
Genes affected
CD36 (HGNC:1663): (CD36 molecule (CD36 blood group)) The protein encoded by this gene is the fourth major glycoprotein of the platelet surface and serves as a receptor for thrombospondin in platelets and various cell lines. Since thrombospondins are widely distributed proteins involved in a variety of adhesive processes, this protein may have important functions as a cell adhesion molecule. It binds to collagen, thrombospondin, anionic phospholipids and oxidized LDL. It directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes and it binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport. Mutations in this gene cause platelet glycoprotein deficiency. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2014]
CD36 Gene-Disease associations (from GenCC):
  • platelet-type bleeding disorder 10
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 7-80656534-T-C is Benign according to our data. Variant chr7-80656534-T-C is described in ClinVar as Benign. ClinVar VariationId is 360750.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.409 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CD36NM_001001548.3 linkc.121-6T>C splice_region_variant, intron_variant Intron 3 of 14 ENST00000447544.7 NP_001001548.1 P16671-1A4D1B1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CD36ENST00000447544.7 linkc.121-6T>C splice_region_variant, intron_variant Intron 3 of 14 5 NM_001001548.3 ENSP00000415743.2 P16671-1

Frequencies

GnomAD3 genomes
AF:
0.134
AC:
20451
AN:
152070
Hom.:
2020
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.210
Gnomad AMI
AF:
0.0219
Gnomad AMR
AF:
0.147
Gnomad ASJ
AF:
0.0706
Gnomad EAS
AF:
0.424
Gnomad SAS
AF:
0.256
Gnomad FIN
AF:
0.0669
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.0711
Gnomad OTH
AF:
0.125
GnomAD2 exomes
AF:
0.143
AC:
35746
AN:
250448
AF XY:
0.142
show subpopulations
Gnomad AFR exome
AF:
0.219
Gnomad AMR exome
AF:
0.177
Gnomad ASJ exome
AF:
0.0769
Gnomad EAS exome
AF:
0.420
Gnomad FIN exome
AF:
0.0725
Gnomad NFE exome
AF:
0.0706
Gnomad OTH exome
AF:
0.105
GnomAD4 exome
AF:
0.0986
AC:
143901
AN:
1460108
Hom.:
11500
Cov.:
31
AF XY:
0.102
AC XY:
73786
AN XY:
726438
show subpopulations
African (AFR)
AF:
0.215
AC:
7181
AN:
33404
American (AMR)
AF:
0.176
AC:
7838
AN:
44640
Ashkenazi Jewish (ASJ)
AF:
0.0751
AC:
1960
AN:
26096
East Asian (EAS)
AF:
0.425
AC:
16801
AN:
39568
South Asian (SAS)
AF:
0.242
AC:
20853
AN:
86168
European-Finnish (FIN)
AF:
0.0749
AC:
3996
AN:
53372
Middle Eastern (MID)
AF:
0.0498
AC:
285
AN:
5722
European-Non Finnish (NFE)
AF:
0.0700
AC:
77767
AN:
1110840
Other (OTH)
AF:
0.120
AC:
7220
AN:
60298
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
5727
11454
17180
22907
28634
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3360
6720
10080
13440
16800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.135
AC:
20483
AN:
152188
Hom.:
2027
Cov.:
32
AF XY:
0.137
AC XY:
10218
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.210
AC:
8731
AN:
41506
American (AMR)
AF:
0.147
AC:
2241
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0706
AC:
245
AN:
3472
East Asian (EAS)
AF:
0.423
AC:
2181
AN:
5152
South Asian (SAS)
AF:
0.257
AC:
1242
AN:
4828
European-Finnish (FIN)
AF:
0.0669
AC:
710
AN:
10614
Middle Eastern (MID)
AF:
0.0476
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
0.0711
AC:
4835
AN:
68014
Other (OTH)
AF:
0.125
AC:
264
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
842
1685
2527
3370
4212
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
226
452
678
904
1130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0929
Hom.:
3999
Bravo
AF:
0.139
Asia WGS
AF:
0.343
AC:
1189
AN:
3478
EpiCase
AF:
0.0672
EpiControl
AF:
0.0681

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 09, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Platelet-type bleeding disorder 10 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
9.1
DANN
Benign
0.74
PhyloP100
1.0
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00030
dbscSNV1_RF
Benign
0.016
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3173798; hg19: chr7-80285850; COSMIC: COSV59212036; API